In Montenegro, the people living with hiv antiretroviral therapy coverage stands at 57%, reflecting an increase of 6% (11.8%) compared to 2021.
People living with HIV antiretroviral therapy coverage in Montenegro
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Montenegro
Male unintentional poisoning
0.4
-0.2
(2021)
Female wasting in children
1.9%
-0.5%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar1,141
+intl dollar131
(2022)
Birth registration
99.4%
+0.5%
(2013)
Contraceptive modern method prevalence
11.6%
-3.8%
(2018)
Montenegro Antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 57% | +6% |
| 2021 | 51% | 0% |
| 2020 | 51% | +2% |
| 2019 | 49% | +3% |
| 2018 | 46% | +3% |
| 2017 | 43% | +6% |
| 2016 | 37% | +5% |
| 2015 | 32% | +1% |
| 2014 | 31% | +3% |
| 2013 | 28% | +3% |
| 2012 | 25% | +1% |
| 2011 | 24% | -1% |
| 2010 | 25% | +3% |
| 2009 | 22% | +1% |
| 2008 | 21% | +1% |
| 2007 | 20% | 0% |
| 2006 | 20% | 0% |
| 2005 | 20% | +5% |
| 2004 | 15% | +2% |
| 2003 | 13% | +2% |
| 2002 | 11% | 0% |
| 2001 | 11% | +3% |
| 2000 | 8% |